Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2017-02-13
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lymphedema Sensor Technology Development Study
NCT06778837
A Study Comparing Powered Ported Bone Marrow Aspiration Procedures to Manual Standard Bone Marrow Aspiration Procedures Using Healthy Volunteers
NCT02299102
An Assessment of the Zephyr BioPatch and Its Ability to Monitor Patient Position
NCT02548624
Minimally-Invasive Realtime Assessment of Continuous Lactate in Exercise
NCT04238611
Non-Invasive Blood Test Cross-Validation Study
NCT03991637
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. RMR with MedGem® Indirect Calorimeter
2. RMR without MedGem® Indirect Calorimeter
Study recruitment will be performed at PBRC. Screening, consenting, and all study procedures will be performed within a single study visit at PBRC within the Inpatient Unit. All subjects will be introduced to the ventilated hood to determine presence of claustrophobia prior to enrollment (i.e., signing of the consent form).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Not holding, then holding the MedGem®
Subjects will be seated in an armless chair and have a RMR measurement taken while not holding, then holding a MedGem® Indirect Calorimeter.
Not holding, then holding the MedGem®
Subjects will have a RMR measurement taken first while not holding the MedGem®, and then while holding the MedGem®
Holding, then not holding the MedGem®
Subjects will have a RMR measurement taken first while holding the MedGem®, and then while not holding the MedGem®
Holding, then not holding the MedGem®
Subjects will be seated in an armless chair and have a RMR measurement taken holding, then not holding a MedGem® Indirect Calorimeter.
Not holding, then holding the MedGem®
Subjects will have a RMR measurement taken first while not holding the MedGem®, and then while holding the MedGem®
Holding, then not holding the MedGem®
Subjects will have a RMR measurement taken first while holding the MedGem®, and then while not holding the MedGem®
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Not holding, then holding the MedGem®
Subjects will have a RMR measurement taken first while not holding the MedGem®, and then while holding the MedGem®
Holding, then not holding the MedGem®
Subjects will have a RMR measurement taken first while holding the MedGem®, and then while not holding the MedGem®
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 25-40 kg/m2
Exclusion Criteria
* Current smoker
* Presently on a weight loss regimen
* Medications: diabetes, oral steroids, blood pressure drugs, weight loss drugs
* Claustrophobia
* Pregnant or breastfeeding
* Congestive heart failure
* Chronic kidney disease
* Pacemaker or other metal implants
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
WW International Inc
INDUSTRY
Pennington Biomedical Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric Ravussin
Associate Executive Director for Clinical Science
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Ravussin, PhD
Role: PRINCIPAL_INVESTIGATOR
Pennington Biomedical Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBRC 2016-086
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.